The Multiple Sclerosis Association of America (MSAA) and Novartis Pharmaceuticals Corporation have collaborated to develop the Multiple Sclerosis Implementation Network™ (MSIN™). This is an exciting and unique initiative to create a practice-based research network (PBRN) for medical professionals to best support individuals with MS. 

MSIN is a patient-centric initiative, emphasizing the vital role of people living with MS and their involvement in this practice-based research network. MSIN will be guided by two advisory boards – one of which will be comprised of people living with MS and their care partners. The other advisory board will be comprised of healthcare professionals, research scientists, and advocacy partners.

The Multiple Sclerosis Association of America (MSAA) is excited to invite members of the MS community to our 10th Improving Lives Benefit on Wednesday, May 15, 2024, at 6:30 pm ET, at the Barnes Foundation in Philadelphia, PA. This event will also be livestreamed, allowing individuals from across the country to participate from the comfort of their homes. Those attending will have the opportunity to connect with inspiring individuals, recognize our special honorees, and support MSAA’s programs and services that are provided at no cost to the MS community.